Green Tea (Cardiac Tea) vs Java Tea (Kidney Tea): A Review

This review is a comprehensive summary of the currently available chemical, pharmacological investigations as well as the traditional and therapeutic potentials of Camellia sinensis (Cardiac tea) and Orthosiphon stamineus leaves (Kidney tea) in heart and kidney diseases. Cardiovascular disease is the most common cause of death in people with chronic kidney disease. Compared to the general population, people with chronic kidney disease are two to three times more likely to have cardiovascular (heart and blood vessel) problems such as angina, heart attack, stroke or heart failure. This increased risk is partly caused by factors common to both chronic kidney disease and cardiovascular disease, such as high blood pressure. However, researchers are discovering that chronic kidney disease is, in itself, an important risk factor for the development of cardiovascular disease, and a history of cardiovascular disease is a risk factor for the development of chronic kidney disease. A range of medication and natural therapy is available for treating heart and kidney diseases. But there is no effective natural therapy is available for prevention and treatment of heart and kidney diseases. Camellia sinensis and Orthosiphon stamineus plant leaves used for prevention and treatment of heart and kidney diseases respectively. Aim of this literature was to review the therapeutic properties of the green tea and java tea for prevention and treatment of heart and kidney diseases.